Commerce Bank Acquires Shares of 2,414 Astera Labs, Inc. $ALAB

Commerce Bank acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,414 shares of the company’s stock, valued at approximately $1,166,000.

A number of other institutional investors have also made changes to their positions in the company. Royal Bank of Canada grew its holdings in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC lifted its holdings in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares in the last quarter. Empowered Funds LLC lifted its holdings in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares in the last quarter. First Trust Advisors LP boosted its position in Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. boosted its position in Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after buying an additional 1,977 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ALAB. JPMorgan Chase & Co. lifted their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Bank of America increased their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Barclays raised their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Susquehanna lifted their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Morgan Stanley upped their target price on Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $333.00.

Insider Activity

In related news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 419,244 shares of company stock valued at $163,135,169 over the last three months. Company insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB stock opened at $282.65 on Wednesday. The firm has a fifty day moving average of $348.88 and a two-hundred day moving average of $247.38. The firm has a market cap of $49.04 billion, a P/E ratio of 139.93 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.